Low Prevalence of Human Papillomavirus (HPV) in Chinese Patients with Breast Cancer

Author： Mou X   Chen L   Liu F   Shen Y   Wang H   Li Y   Yuan L   Lin J   Lin J   Teng L   Xiang C  

Publisher： Field House Publishing

ISSN： 0300-0605

Source： The Journal of International Medical Research, Vol.39, Iss.5, 2011-09, pp. : 1636-1644

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

What is the best treatment for patients with human papillomavirus–positive and –negative oropharyngeal cancer?

By Urban Damien   Corry June   Rischin Danny  

Cancer, Vol. 120, Iss. 10, 2014-05 ,pp. : 1462-1470

Blackwell Publishing

Access to resources Recommend Favorite

AS04-Adjuvanted Human Papillomavirus (HPV) Types 16 and 18 Vaccine (Cervarix®): A Review of its Use in the Prevention of Premalignant Cervical Lesions and Cervical Cancer Causally Related to Certain Oncogenic HPV Types

By McKeage Kate  

Drugs, Vol. 71, Iss. 4, 2011-03 ,pp. : 465-468

Adis International

Access to resources Recommend Favorite

Human papillomavirus (HPV) vaccine prevents cervical precancers and noninvasive cervical cancers

By  

Inpharma, Vol. 1, Iss. 1509, 2005-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Circulating human papillomavirus DNA as a marker for disease extent and recurrence among patients with oropharyngeal cancer

By  

Cancer, Vol. 121, Iss. 19, 2015-10 ,pp. : 3455-3464

Blackwell Publishing

Access to resources Recommend Favorite

Human papillomavirus: science and technologies for the elimination of cervical cancer

By Bosch F Xavier  

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 14, 2011-10 ,pp. : 2189-2204

Informa Healthcare

Access to resources Recommend Favorite